Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Paclitaxel in Treating Older Patients With Solid Tumors

ClinicalTrials.gov ID: NCT00003092

Public ClinicalTrials.gov record NCT00003092. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 7:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Pharmacology of Paclitaxel in Relation to Patient Age

Study identification

NCT ID
NCT00003092
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
120 participants

Conditions and interventions

Interventions

  • paclitaxel Drug

Drug

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 1997
Primary completion
Feb 28, 2006
Completion
May 31, 2006
Last update posted
Jul 13, 2016

1997 – 2006

United States locations

U.S. sites
32
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
Rebecca and John Moores UCSD Cancer Center La Jolla California 92093-0658
UCSF Cancer Center and Cancer Research Institute San Francisco California 94143-0128
CCOP - Christiana Care Health Services Wilmington Delaware 19899
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5000
CCOP - Mount Sinai Medical Center Miami Beach Florida 33140
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Holden Comprehensive Cancer Center Iowa City Iowa 52242-1009
Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland 21201
Dana-Farber Cancer Institute Boston Massachusetts 02115
University of Massachusetts Memorial Medical Center - University Campus Worcester Massachusetts 01655
University of Minnesota Cancer Center Minneapolis Minnesota 55455
Ellis Fischel Cancer Center - Columbia Columbia Missouri 65203
Barnes-Jewish Hospital St Louis Missouri 63110
University of Nebraska Medical Center Omaha Nebraska 68198-7680
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106
Norris Cotton Cancer Center Lebanon New Hampshire 03756-0002
Roswell Park Cancer Institute Buffalo New York 14263-0001
CCOP - North Shore University Hospital Manhasset New York 11030
North Shore University Hospital Manhasset New York 11030
Memorial Sloan-Kettering Cancer Center New York New York 10021
New York Presbyterian Hospital - Cornell Campus New York New York 10021
Mount Sinai Medical Center, NY New York New York 10029
State University of New York - Upstate Medical University Syracuse New York 13210
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. Syracuse New York 13217
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295
Duke Comprehensive Cancer Center Durham North Carolina 27710
CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina 27104-4241
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1082
Rhode Island Hospital Providence Rhode Island 02903
University of Tennessee Cancer Institute Memphis Tennessee 38103
Vermont Cancer Center Burlington Vermont 05401-3498
MBCCOP - Massey Cancer Center Richmond Virginia 23298-0037

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003092, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2016 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003092 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →